Neuro-Oncology is a specialized field of oncology that focuses on cancers affecting the brain, spinal cord, and other components of the central nervous system. These tumors include both primary brain cancers and metastatic tumors that spread to the nervous system from other parts of the body. Advances in diagnosis, treatment technologies, and molecular research related to nervous system tumors are often presented at global scientific meetings such as an Oncology Conference, where clinicians and researchers explore innovative strategies for managing central nervous system tumors.

Neuro-oncology integrates multiple scientific disciplines including neurology, oncology, radiology, neurosurgery, and pathology to understand the complex biology of brain and spinal cord tumors. Tumors of the central nervous system can originate from different types of cells, including glial cells, neurons, or supportive tissues within the brain. Genetic mutations and alterations in cellular signaling pathways can disrupt normal neural cell growth, leading to the formation of tumors. Because the brain controls essential bodily functions, even small tumors may significantly affect neurological health.

The symptoms of central nervous system tumors vary depending on tumor location, size, and growth rate. Patients may experience headaches, seizures, changes in vision, memory loss, or difficulty with balance and coordination. In some cases, tumors may increase intracranial pressure by blocking the normal flow of cerebrospinal fluid within the brain. Early and accurate diagnosis is essential for effective management. Physicians rely on imaging techniques such as magnetic resonance imaging and computed tomography scans, along with biopsy procedures, to identify tumor type and determine disease stage.

Treatment approaches in neuro-oncology are carefully designed to remove or control tumors while preserving neurological function. Surgery is often the first line of treatment when tumors can be safely removed. Radiation therapy and chemotherapy may also be used to destroy remaining cancer cells or control tumor growth. Advances in targeted therapies and immunotherapy are expanding treatment options for patients with brain tumors. Ongoing research continues to investigate tumor genetics, novel drug therapies, and advanced surgical techniques that may improve survival and quality of life for individuals diagnosed with cancers of the central nervous system.